PlaqueTec

PlaqueTec has raised £3.7m in an oversubscribed financing round funded by its existing investor base to develop its cardiovascular disease database. Summary of transaction details: Value: £3.7m Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: PlaqueTec, existing investor base Location: Cambridge, UK Note: The funding will support the continued build-out of PlaqueTec's proprietary cardiovascular data lake, BioCarta, which aims to provide a novel site-of-disease strategy to inform how inflammatory risk in CVD is targeted.